Cargando…
The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial
BACKGROUND: The care needs of patients with a limited prognosis (<12 months median) are complex and dynamic. Patients and caregivers must cope with many challenges, including physical symptoms and disabilities, uncertainty. and compromised self-efficacy. Healthcare is often characterized by disru...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092809/ https://www.ncbi.nlm.nih.gov/pubmed/30107809 http://dx.doi.org/10.1186/s13063-018-2814-1 |
_version_ | 1783347595429543936 |
---|---|
author | Siegle, Anja Villalobos, Matthias Bossert, Jasmin Krug, Katja Hagelskamp, Laura Krisam, Johannes Handtke, Violet Deis, Nicole Jünger, Jana Wensing, Michel Thomas, Michael |
author_facet | Siegle, Anja Villalobos, Matthias Bossert, Jasmin Krug, Katja Hagelskamp, Laura Krisam, Johannes Handtke, Violet Deis, Nicole Jünger, Jana Wensing, Michel Thomas, Michael |
author_sort | Siegle, Anja |
collection | PubMed |
description | BACKGROUND: The care needs of patients with a limited prognosis (<12 months median) are complex and dynamic. Patients and caregivers must cope with many challenges, including physical symptoms and disabilities, uncertainty. and compromised self-efficacy. Healthcare is often characterized by disruptions in the transition between healthcare providers. The Milestones Communication Approach (MCA) is a structured, proactive, interprofessional concept that involves physicians and nurses and is aimed at providing coherent care across the disease trajectory. This study aims to evaluate these aspects of MCA: (1) the training of healthcare professionals, (2) implementation context and outcomes, (3) patient outcomes, and (4) effects on interprofessional collaboration. METHODS/DESIGN: A multiphase mixed-methods design will be used for the study. A total of 100 patients and 120 healthcare professionals in a specialized oncology hospital will be involved. The training outcomes will be documented using a questionnaire. Implementation context and outcomes will be explored through semi-structured interviews and written questionnaires with healthcare professionals and with the training participants and through a content analysis of patient files. Patient outcomes will be assessed in a pragmatic non-blinded randomized controlled trial and in qualitative interviews with patients and caregivers. Trial outcomes are supportive care needs (SCNS-SF34-G), quality of life (SeiQol and Fact-L), depression and anxiety symptoms (PHQ-4), and distress (Distress Thermometer). Qualitative semi-structured interviews on patients’ views will focus on shared decision-making, communication needs, feeling empathy, and further utilization of healthcare services. Interprofessional collaboration will be explored using the UWE-IP-D before the implementation of MCA (t0) and after 3 (t1), 9 (t2), and 12 (t3) months. DISCUSSION: Using guideline-concordant early palliative care, MCA aims to foster patient-centered communication with shared decision-making and facilitation of advance care planning including end-of-life decisions, thus increasing patient quality of life and decreasing aggressive medical care at the end of life. It is assumed that the communication skills training and interprofessional coaching will improve the communication behavior of healthcare providers and influence team communications and team processes. TRIAL REGISTRATION: German Clinical Trials Register, DRKS00013649 and DRKS00013469. Registered on 22 December 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13063-018-2814-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6092809 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60928092018-08-20 The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial Siegle, Anja Villalobos, Matthias Bossert, Jasmin Krug, Katja Hagelskamp, Laura Krisam, Johannes Handtke, Violet Deis, Nicole Jünger, Jana Wensing, Michel Thomas, Michael Trials Study Protocol BACKGROUND: The care needs of patients with a limited prognosis (<12 months median) are complex and dynamic. Patients and caregivers must cope with many challenges, including physical symptoms and disabilities, uncertainty. and compromised self-efficacy. Healthcare is often characterized by disruptions in the transition between healthcare providers. The Milestones Communication Approach (MCA) is a structured, proactive, interprofessional concept that involves physicians and nurses and is aimed at providing coherent care across the disease trajectory. This study aims to evaluate these aspects of MCA: (1) the training of healthcare professionals, (2) implementation context and outcomes, (3) patient outcomes, and (4) effects on interprofessional collaboration. METHODS/DESIGN: A multiphase mixed-methods design will be used for the study. A total of 100 patients and 120 healthcare professionals in a specialized oncology hospital will be involved. The training outcomes will be documented using a questionnaire. Implementation context and outcomes will be explored through semi-structured interviews and written questionnaires with healthcare professionals and with the training participants and through a content analysis of patient files. Patient outcomes will be assessed in a pragmatic non-blinded randomized controlled trial and in qualitative interviews with patients and caregivers. Trial outcomes are supportive care needs (SCNS-SF34-G), quality of life (SeiQol and Fact-L), depression and anxiety symptoms (PHQ-4), and distress (Distress Thermometer). Qualitative semi-structured interviews on patients’ views will focus on shared decision-making, communication needs, feeling empathy, and further utilization of healthcare services. Interprofessional collaboration will be explored using the UWE-IP-D before the implementation of MCA (t0) and after 3 (t1), 9 (t2), and 12 (t3) months. DISCUSSION: Using guideline-concordant early palliative care, MCA aims to foster patient-centered communication with shared decision-making and facilitation of advance care planning including end-of-life decisions, thus increasing patient quality of life and decreasing aggressive medical care at the end of life. It is assumed that the communication skills training and interprofessional coaching will improve the communication behavior of healthcare providers and influence team communications and team processes. TRIAL REGISTRATION: German Clinical Trials Register, DRKS00013649 and DRKS00013469. Registered on 22 December 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13063-018-2814-1) contains supplementary material, which is available to authorized users. BioMed Central 2018-08-14 /pmc/articles/PMC6092809/ /pubmed/30107809 http://dx.doi.org/10.1186/s13063-018-2814-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Siegle, Anja Villalobos, Matthias Bossert, Jasmin Krug, Katja Hagelskamp, Laura Krisam, Johannes Handtke, Violet Deis, Nicole Jünger, Jana Wensing, Michel Thomas, Michael The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial |
title | The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial |
title_full | The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial |
title_fullStr | The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial |
title_full_unstemmed | The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial |
title_short | The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial |
title_sort | heidelberg milestones communication approach (mca) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092809/ https://www.ncbi.nlm.nih.gov/pubmed/30107809 http://dx.doi.org/10.1186/s13063-018-2814-1 |
work_keys_str_mv | AT siegleanja theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT villalobosmatthias theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT bossertjasmin theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT krugkatja theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT hagelskamplaura theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT krisamjohannes theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT handtkeviolet theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT deisnicole theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT jungerjana theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT wensingmichel theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT thomasmichael theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT siegleanja heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT villalobosmatthias heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT bossertjasmin heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT krugkatja heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT hagelskamplaura heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT krisamjohannes heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT handtkeviolet heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT deisnicole heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT jungerjana heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT wensingmichel heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial AT thomasmichael heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial |